1. Medtech Insight
  2. >>Business

Johnson & Johnson Joins Forces With Veracyte For Lung Cancer Diagnostics

 
• By Catherine Longworth

Johnson & Johnson has entered a strategic collaboration with genomics diagnostics company Veracyte to develop and commercialize tests for detecting lung cancer.

Lungs

Johnson & Johnson (J&J) has signed a collaboration deal with genomics diagnostics company Veracyte Inc. to advance the development of two nasal swab tests for early lung cancer detection.

Under the terms of the agreement, the Lung Cancer Initiative at J&J and Veracyte will combine clinical study cohorts with...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

FDA’s Small Business Eligibility Process Gets Update Before New Fiscal Year

 
• By Elizabeth Orr

The US FDA has updated its guidance document on small business eligibility determinations for medical device firms. Industry observers urge companies to ask for the status early to avoid any potential hold-ups.

Thermo Fisher Margins Feel The Weight Of Tariffs Even As China Trade Pressures Ease In Q2

 
• By Shubham Singh

Thermo Fisher said the year-over-year impact of tariffs and related effects represented a 5% headwind to adjusted operating income and reduced reported margins by 140 basis points in the second quarter.

NIH-Backed Scanner Opens New Frontier For Understanding The Human Brain

 
• By Brian Bossetta

A new MRI scanner developed by a team of scientists working with the National Institutes of Health marks a milestone in understanding the complexities of the human brain. Andrea Beckel-Mitchener with the NIH Brain Initiative discusses the significance of this potentially game-changing device.